Publication | Open Access
Nociceptin/orphanin FQ (N/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma
27
Citations
41
References
2016
Year
We demonstrated a novel dual airway immunomodulator/bronchodilator role for N/OFQ and suggest targeting this system as an innovative treatment for asthma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1